Impact of adiposity on immunological parameters;Impacto da adiposidade nos parâmetros imunológicos

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 53, Issue 2, 2009, Pages 183-189

  Moulin, Cristiane Martins ^a   Marguti, Ivo ^a   Peron, Jean Pierre S ^a   Rizzo, Luiz Vicente ^a,b   Halpern, Alfredo ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

Author keywords

Adipose tissue; Immunity; Obesity; Weight loss

Indexed keywords

EID: 67649450189     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/S0004-27302009000200010     Document Type: Review

References (60)

1. WHO Consultation on obesity. Obesity: preventing and managing the global epidemic. WHO Tech Rep Series no 894. Geneva, Switzerland: World Health Organization; 2000.
2. Martí A, Marcos A, Martínez JA. Obesity and immune function relationships. Obes Rev. 2001;2(2):131-40.
3. Janeway CA, Travers P, Walport M, Sholmchik MJ. Immunobiology: the immune system in health and disease. 6th edition. Garland Science Publishing Inc.: New York; 2005.
4. Lamas O, Martinez JA, Marti A. T helper lymphopenia and decreased mitogenic response in cafeteria diet-induced obese rats. Nutr Res. 2002;22:496-507.
5. Lamas O, Martinez JA, Marti A. Energy restriction restores the impaired immune response in overweight (cafeteria) rats. J Nutr Biochem. 2004;15(7):418-25.
6. Katagiri K, Arakawa S, Kurahashi R, Hatano Y. Impaired contact hypersensitivity in diet-induced obese mice. J Dermatol Sci. 2007;46(2):117-26.
7. Smith AG, Sheridan PA, Harp JB, Beck MA. Diet-induced obese mice have increased mortality and altered immune responses when infected with influenza virus. J Nutr. 2007;137(5):1236-43.
8. Falagas ME, Kompoti M. Obesity and infection. Lancet Infect Dis. 2006;6(7):438-46.
9. Weber DJ, Rutala WA, Samsa GP, Santimaw JE, Lemon SM. Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine. JAMA. 1985;254(22):3187-9.
10. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004;4(8):579-91.
11. Ceschi M, Gutzwiller F, Moch H, Eichholzer M, Probst-Hensch NM. Epidemiology and pathophysiology of obesity as cause of cancer. Swiss Med Wkly. 2007;137(3-4):50-6.
12. Kim R, Emi M, Tanabe K. Cancer immunoediting from immune surveillance to immune escape. Immunology. 2007;121(1):1-14.
13. Nieman DC, Nehlsen-Cannarella SL, Henson DA, Butterworth DE, Fagoaga OR, Warren BJ, et al. Immune response to obesity and moderate weight loss. Int J Obes. 1996;20(4):353-60.
14. Tanaka S, Inoue S, Isoda F, Waseda M, Ishihara M, Yamakawa T, et al. Impaired immunity in obesity: suppressed but reversible lymphocyte responsiveness. Int J Obes. 1993;17(11):631-6.
15. Tanaka S, Isoda F, Ishihara Y, Kimura M, Yamakawa T. T lymphopaenia in relation to body mass index and TNF-α in human obesity: adequate weight reduction can be corrective. Clin Endocrinol. 2001;54(3):347-54.
16. Chandra RK, Kutty KM. Immunocompetence in obesity. Acta Paediatr Scand. 1980;69(1):25-30.
17. Moriguchi S, Kato M, Sakai K, Yamamoto S, Shimizu E. Decreased mitogen response of splenic lymphocytes in obese Zucker rats is associated with the decreased expression of glucose transporter 1 (GLUT-1). Am J Clin Nutr. 1998;67(6):1124-9.
18. Krishnan EC, Trost L, Aarons S, Jewell WR. Study of function and maturation of monocytes in morbidly obese individuals. J Surg Res. 1982;33(2):89-97.
19. Palmblad J, Hallberg D, Engsted L. Polymorphonuclear (PMN)function after small intestinal shunt operation for morbid obesity. Br J Haematol. 1980;44(1):101-8.
20. Cottam DR, Schaefer PA, Shaftan GW, Angus LD. Dysfunctional immune-privilege in morbid obesity: implications and effect of gastric bypass surgery. Obes Surg. 2003;13(1):49-57.
21. Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol. 2006;6(10):772-83.
22. Fhühbeck G, Gómez-Ambrosi J, Muruzábal FJ, Burrell MA. The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. Am J Physiol Endocrinol Metab. 2001;280(6):E827-47.
23. Cousin B, Munoz O, Andre M, Fontanilles AM, Dani C, Cousin JL, et al. A role for preadipocytes as macrophage-like cells. FASEB J. 1999;13(2):305-12.
24. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante Jr AW. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003;112 (12):1796-808.
25. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis. 2000;148(2):209-214.
26. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-: direct role in obesity-linked insulin resistance. Science. 1993;259(5091):87-91.
27. Geloneze B, Tambascia MA, Pareja JC, Repetto EM, Magna LA, Pereira SG. Serum leptin levels after bariatric surgery across a range of glucose tolerance from normal to diabetes. Obes Surg. 2001;11(6):693-8.
28. Matarese G, Moschos S, Mantzoros CS. Leptin in immunology. J Immunol. 2005;174(6):3137-42.
29. Chan JL, Matarese G, Shetty GK, Raciti P, Kelesidis I, Aufiero D, et al. Differential regulation of metabolic, neuroendocrine, and immune function by leptin in humans. PNAS. 2006;103(22):8481-6.
30. Loffreda S, Yang SQ, Lin HZ, Karp CL, Brengman ML, Wang DJ, et al. Leptin regulates proinflammatory immune responses. FASEB J. 1998;12(1):57-65.
31. Tanaka S, Isoda F, Yamakawa T, Ishihara M, Sekihara H. T lymphopenia in genetically obese rats. Clin Immunol Immunopathol. 1998;86(2):219-225.
32. Hick RW, Gruver AL, Ventevogel MS, Haynes BF, Sempowski GD. Leptin selectively augments thymopoiesis in leptin deficiency and lipopolysaccharide-induced thymic atrophy. J Immunol. 2006;177(1):169-76.
33. Macia L, Delacre M, Abboud G, Ouk TS, Delanoye A, Verwaerde C, et al. Impairment of dendritic cell functionality and steady-state number in obese mice. J Immunol. 2006;177(9):5997-6006.
34. Farooqi IS, Matarese G, Lord GM, Keogh JM, Lawrence E, Agwu C, et al. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest. 2002;110(8):1093-103.
35. Mito N, Yoshino H, Hosoda T, Sato K. Analysis of effect of leptin on immune function in vivo using diet-induced obese mice. J Endocrinol. 2003;180(1):167-73.
36. Nave H, Mueller G, Siegmund B, Jacobs R, Stroh T, Schueler U, et al. Resistance of JAK-2 dependent leptin signaling in NK cells: a novel mechanism of NK cell dysfunction in diet-induced obesity. Endocrinology. 2008;149(7):3370-8.
37. Papathanassoglou E, El-Haschimi K, Li XC, Matarese G, Strom T, Mantzoros C. Leptin receptor expression and signaling in lymphocytes: kinetics during lymphocyte activation, role in lymphocyte survival, and response to high fat diet in mice. J Immunol. 2006;176(12):7745-52.
38. Rudd PM, Elliott T, Cresswell P, Wilson IA, Dwek RA. Glycosylation and the immune system. Science. 2001;291(5512):2370-6.
39. Mol MJ, Demacker PN, Stalenhoef AF. The role of modification of lipoproteins and of the immune system in early atherogenesis. Neth J Med. 1993;43(1-2):83-90.
40. de Pablo MA, Alvarez de Cienfuegos G. Modulatory effects of dietary lipids on immune system functions. Immunol Cell Biol. 2000;78(1):31-9.
41. Verwaerde C, Delanoye A, Macia L, Tailleux A, Wolowczuk I. Influence of high-fat feeding on both naive and antigen-experienced T-cell immune response in DO10.11 mice. Scand J Immunol. 2006;64(5):457-66.
42. Barone J, Hebert JR, Reddy MM. Dietary fat and natural-killer-cell activity. Am J Clin Nutr. 1989;50(4):861-7.
43. Miller WC, Lindeman AK, Wallace J, Niederpruem M. Diet composition, energy intake and exercise in relation to body fat in men and women. Am J Clin Nutr. 1990;52(3):426-30.
44. Wing EJ, Stanko RT, Winkelstein A, Adibi SA. Fasting-enhanced immune effector mechanisms in obese subjects. Am J Med. 1983;75(1):91-6.
45. Dixit VD. Adipose-immune interactions during obesity and caloric restriction: reciprocal mechanisms regulating immunity and health span. J Leukoc Biol. 2008;84(4):1-11.
46. Kelley DS, Daudu PA, Branch LB, Johnson HL, Taylor PC, Mackey B. Energy restriction decreases number of circulating natural killer and serum levels of immunoglobulins in overweight women. Eur J Clin Nutr. 1994;48(1):9-18.
47. Scanga CB, Verde TJ, Paolone AM, Andersen RE, Wadden TA. Effects of weight loss and exercise training on natural killer cell activity in obese women. Med Sci Sports Exerc. 1998;30(12):1666-71.
48. Field CJ, Gougeon R, Marliss EB. Changes in circulating leukocytes and mitogen responses during very-low-energy all-protein reducing diets. Am J Clin Nutr. 1991;54(1):123-9.
49. Herron DM. The surgical management of severe obesity. The Mount Sinai J Med. 2004;71(1):63-71.
50. Hallberg D, Nilsson BS, Backman L. Immunological function in patients operated on with small intestinal shunts for morbid obesity. Scand J Gastroenterol. 1976;11(1):41-8.
51. Tustin AW, Kaiser AB, Bradsher RW, Herrington JL. Unusual fungal infections following jejunoileal bypass surgery. Arch Intern Med. 1980;140(5):643-5.
52. Hanusch-Enserer U, Cauza E, Spak M, Dunky A, Rosen HR, Wolf H, et al. Acute-phase response and immunological markers in morbid obese patients and patients following adjustable gastric banding. Int J Obes Relat Metab Disord. 2003;27(3):355-61.
53. Dixon JB, O'Brien PE. Obesity and the white blood cell count: changes with sustained weight loss. Obes Surg. 2006;16(3):251-7.
54. van Dielen FM, Buurman WA, Hadfoune M, Nijhuis J, Greve JW. Macrophage inhibitory factor, plasminogen activator inhibitor-1, other acute phase proteins, and inflammatory mediators normalize as a result of weight loss in morbidly obese subjects treated with gastric restrictive surgery. J Clin Endocrinol Metab. 2004;89(8):4062-8.
55. Kyzer S, Binyamini J, Chaimoff C, Fishman P. The effect of surgically induced weight reduction on the serum levels of the cytokines: interleukin-3 and tumor necrosis factor. Obes Surg. 1999;9(3):229-34.
56. Manco M, Fernadez-Real JM, Equitani F, Vendrell J, Mora MEV, Nanni G, et al. Effect of massive weight loss on inflammatory adipocytokines and the innate immune system in morbidly obese women. J Clin Endocrinol Metab. 2007;92(2):483-90.
57. McAuliffe PF, Efron PA, Scumpia PO, Uchida T, Mutschlecner SC, Rout WR, et al. Varying blood monocyte and dendritic cell responses after laparoscopic versus open gastric bypass surgery. Obes Surg. 2005;15(10):1424-31.
58. Vilarrasa N, Vendrell J, Sánchez-Santos R, Broch M, Megia A, Masdevall C, et al. Effect of weight loss induced by gastric bypass on proinflammatory interleukin-18, soluble tumor necrosis factoralpha receptors, C-reactive protein and adiponectin in morbidly obese patients. Clin Endocrinol. 2007;67(5):679-86.
59. Fontana L, Eagon JC, Colonna M, Klein S. Impaired mononuclear cell immune function in extreme obesity is corrected by weight loss. Rejuvenation Res. 2007;10(1):41-6.
60. Hallett WH, Murphy WJ. Positive and negative regulation of natural killer cells: therapeutic implications. Sem Cancer Biol. 2006;16(5):367-82.